PROGLUMETACINA: ANTIREUMATICO FLESSIBILE E AD AMPIO SPETTRO

Translated title of the contribution: Proglumetacin: A flexible and wide-spectrum anti-rheumatic drug in clinical practice

G. Fontanesi, F. Giancecchi, R. Rotini, I. Tartaglia

Research output: Contribution to journalArticlepeer-review

Abstract

Fifty-five patients with osteoarthritis, rheumatoid arthritis or spondyloarthritis, joint pain and other rheumatic-inflammatory disorders were treated with proglumetacin, at different doses, during 3-60 days. Assessment of therapeutic efficacy indicated 88.9% of good results. Joint pain progressively decreased during the whole period of observation. Tolerance was considered good or very good in 78% of patients.

Translated title of the contributionProglumetacin: A flexible and wide-spectrum anti-rheumatic drug in clinical practice
Original languageItalian
Pages (from-to)1547-1551
Number of pages5
JournalMinerva Medica
Volume74
Issue number26
Publication statusPublished - 1983

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Proglumetacin: A flexible and wide-spectrum anti-rheumatic drug in clinical practice'. Together they form a unique fingerprint.

Cite this